title: Hypercholesterolemia and atherosclerosis: present and future therapy including LDL-apheresis.
abstract: Atherosclerosis-induced coronary heart disease remains the major cause of death and disability in industrialized countries. Hypercholesterolemia is recognized as a causative factor in the development of atherosclerosis. While the lowering of cholesterol levels as a treatment goal has met with general agreement and acceptance, the preferred methods for doing so are still open to conjecture. This literature review discusses various factors in the hypercholesterolemia-atherosclerosis link and surveys a variety of treatment protocols including diet modification, drug therapy, surgical intervention, and plasmapheresis. Evidence is accumulating to prove that the ideal hypercholesterolemia therapy is one that reduces LDL levels while maintaining or increasing HDL levels. Because LDL-apheresis has this potential, this paper also reviews the various LDL-apheresis methods, including immunoadsorption, chemical affinity, and double-membrane filtration.
authors.affiliation: Cardiovascular Research Unit, Mayo Clinic, Rochester, Minnesota 55903.
authors.forename: B A
authors.initials: BA
authors.lastname: Kottke
authors.forename: A A
authors.initials: AA
authors.lastname: Pineda
authors.forename: M T
authors.initials: MT
authors.lastname: Case
authors.forename: A M
authors.initials: AM
authors.lastname: Orsuzar
authors.forename: K A
authors.initials: KA
authors.lastname: Brzys
mesh_terms: D000818:Animals; D001161:Arteriosclerosis / Q000209:etiology / Q000628:therapy*; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood*; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications / Q000628:therapy*; D009316:National Institutes of Health (U.S.); D010956:Plasmapheresis / Q000379:methods*; D014481:United States
chemical_list: D008076:Cholesterol, HDL; D008078:Cholesterol, LDL